The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Highlights
The global Nano-based Drug Delivery System market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Nano-based Drug Delivery System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Nano-based Drug Delivery System is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The global market for Nano-based Drug Delivery System in Hydrophilic Drugs is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global companies of Nano-based Drug Delivery System include Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi and Pfizer, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Less than 50nm, which accounted for % of the global market of Nano-based Drug Delivery System in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nano-based Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nano-based Drug Delivery System.
The Nano-based Drug Delivery System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Nano-based Drug Delivery System market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nano-based Drug Delivery System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Some of the prominent players reviewed in the research report include:
- Amgen
- Teva
- Roche
- UCB (Union Chimique Belge)
- Celgene
- Merck
- Gilead Sciences
- Sanofi
- Pfizer
- Takeda
- Bausch&Lomb
- Samyang Biopharmaceuticals
- Johnson & Johnson
- TOLMAR
- Astellas
- AMAG Pharmaceuticals
- AbbVie
- Dr Reddy
- AstraZeneca
- Aspen
- Acrotech Biopharma
- TWi Pharmaceuticals
Product Type Insights
Global markets are presented by Nano-based Drug Delivery System type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Nano-based Drug Delivery System are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Nano-based Drug Delivery System segment by Type
- Less than 50nm
- 50-150nm
- 150-300nm
- Others
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Nano-based Drug Delivery System market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Nano-based Drug Delivery System market.
Nano-based Drug Delivery System Segment by Application
- Hydrophilic Drugs
- Hydrophobic Drugs
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
- Latin America (Mexico, Brazil, Rest of Latin America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Nano-based Drug Delivery System market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nano-based Drug Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Nano-based Drug Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Nano-based Drug Delivery System industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nano-based Drug Delivery System.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nano-based Drug Delivery System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nano-based Drug Delivery System Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Less than 50nm
1.2.3 50-150nm
1.2.4 150-300nm
1.2.5 Others
1.3 Market by Application
1.3.1 Global Nano-based Drug Delivery System Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hydrophilic Drugs
1.3.3 Hydrophobic Drugs
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nano-based Drug Delivery System Market Perspective (2017-2028)
2.2 Nano-based Drug Delivery System Growth Trends by Region
2.2.1 Nano-based Drug Delivery System Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Nano-based Drug Delivery System Historic Market Size by Region (2017-2022)
2.2.3 Nano-based Drug Delivery System Forecasted Market Size by Region (2023-2028)
2.3 Nano-based Drug Delivery System Market Dynamics
2.3.1 Nano-based Drug Delivery System Industry Trends
2.3.2 Nano-based Drug Delivery System Market Drivers
2.3.3 Nano-based Drug Delivery System Market Challenges
2.3.4 Nano-based Drug Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nano-based Drug Delivery System Players by Revenue
3.1.1 Global Top Nano-based Drug Delivery System Players by Revenue (2017-2022)
3.1.2 Global Nano-based Drug Delivery System Revenue Market Share by Players (2017-2022)
3.2 Global Nano-based Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nano-based Drug Delivery System Revenue
3.4 Global Nano-based Drug Delivery System Market Concentration Ratio
3.4.1 Global Nano-based Drug Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nano-based Drug Delivery System Revenue in 2021
3.5 Nano-based Drug Delivery System Key Players Head office and Area Served
3.6 Key Players Nano-based Drug Delivery System Product Solution and Service
3.7 Date of Enter into Nano-based Drug Delivery System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nano-based Drug Delivery System Breakdown Data by Type
4.1 Global Nano-based Drug Delivery System Historic Market Size by Type (2017-2022)
4.2 Global Nano-based Drug Delivery System Forecasted Market Size by Type (2023-2028)
5 Nano-based Drug Delivery System Breakdown Data by Application
5.1 Global Nano-based Drug Delivery System Historic Market Size by Application (2017-2022)
5.2 Global Nano-based Drug Delivery System Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Nano-based Drug Delivery System Market Size (2017-2028)
6.2 North America Nano-based Drug Delivery System Market Size by Country (2017-2022)
6.3 North America Nano-based Drug Delivery System Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Nano-based Drug Delivery System Market Size (2017-2028)
7.2 Europe Nano-based Drug Delivery System Market Size by Country (2017-2022)
7.3 Europe Nano-based Drug Delivery System Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nano-based Drug Delivery System Market Size (2017-2028)
8.2 Asia-Pacific Nano-based Drug Delivery System Market Size by Country (2017-2022)
8.3 Asia-Pacific Nano-based Drug Delivery System Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Nano-based Drug Delivery System Market Size (2017-2028)
9.2 Latin America Nano-based Drug Delivery System Market Size by Country (2017-2022)
9.3 Latin America Nano-based Drug Delivery System Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nano-based Drug Delivery System Market Size (2017-2028)
10.2 Middle East & Africa Nano-based Drug Delivery System Market Size by Country (2017-2022)
10.3 Middle East & Africa Nano-based Drug Delivery System Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Nano-based Drug Delivery System Introduction
11.1.4 Amgen Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.1.5 Amgen Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Nano-based Drug Delivery System Introduction
11.2.4 Teva Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.2.5 Teva Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Nano-based Drug Delivery System Introduction
11.3.4 Roche Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.3.5 Roche Recent Development
11.4 UCB (Union Chimique Belge)
11.4.1 UCB (Union Chimique Belge) Company Detail
11.4.2 UCB (Union Chimique Belge) Business Overview
11.4.3 UCB (Union Chimique Belge) Nano-based Drug Delivery System Introduction
11.4.4 UCB (Union Chimique Belge) Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.4.5 UCB (Union Chimique Belge) Recent Development
11.5 Celgene
11.5.1 Celgene Company Detail
11.5.2 Celgene Business Overview
11.5.3 Celgene Nano-based Drug Delivery System Introduction
11.5.4 Celgene Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.5.5 Celgene Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Nano-based Drug Delivery System Introduction
11.6.4 Merck Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.6.5 Merck Recent Development
11.7 Gilead Sciences
11.7.1 Gilead Sciences Company Detail
11.7.2 Gilead Sciences Business Overview
11.7.3 Gilead Sciences Nano-based Drug Delivery System Introduction
11.7.4 Gilead Sciences Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.7.5 Gilead Sciences Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Nano-based Drug Delivery System Introduction
11.8.4 Sanofi Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.8.5 Sanofi Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Nano-based Drug Delivery System Introduction
11.9.4 Pfizer Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.9.5 Pfizer Recent Development
11.10 Takeda
11.10.1 Takeda Company Detail
11.10.2 Takeda Business Overview
11.10.3 Takeda Nano-based Drug Delivery System Introduction
11.10.4 Takeda Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.10.5 Takeda Recent Development
11.11 Bausch&Lomb
11.11.1 Bausch&Lomb Company Detail
11.11.2 Bausch&Lomb Business Overview
11.11.3 Bausch&Lomb Nano-based Drug Delivery System Introduction
11.11.4 Bausch&Lomb Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.11.5 Bausch&Lomb Recent Development
11.12 Samyang Biopharmaceuticals
11.12.1 Samyang Biopharmaceuticals Company Detail
11.12.2 Samyang Biopharmaceuticals Business Overview
11.12.3 Samyang Biopharmaceuticals Nano-based Drug Delivery System Introduction
11.12.4 Samyang Biopharmaceuticals Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.12.5 Samyang Biopharmaceuticals Recent Development
11.13 Johnson & Johnson
11.13.1 Johnson & Johnson Company Detail
11.13.2 Johnson & Johnson Business Overview
11.13.3 Johnson & Johnson Nano-based Drug Delivery System Introduction
11.13.4 Johnson & Johnson Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.13.5 Johnson & Johnson Recent Development
11.14 TOLMAR
11.14.1 TOLMAR Company Detail
11.14.2 TOLMAR Business Overview
11.14.3 TOLMAR Nano-based Drug Delivery System Introduction
11.14.4 TOLMAR Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.14.5 TOLMAR Recent Development
11.15 Astellas
11.15.1 Astellas Company Detail
11.15.2 Astellas Business Overview
11.15.3 Astellas Nano-based Drug Delivery System Introduction
11.15.4 Astellas Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.15.5 Astellas Recent Development
11.16 AMAG Pharmaceuticals
11.16.1 AMAG Pharmaceuticals Company Detail
11.16.2 AMAG Pharmaceuticals Business Overview
11.16.3 AMAG Pharmaceuticals Nano-based Drug Delivery System Introduction
11.16.4 AMAG Pharmaceuticals Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.16.5 AMAG Pharmaceuticals Recent Development
11.17 AbbVie
11.17.1 AbbVie Company Detail
11.17.2 AbbVie Business Overview
11.17.3 AbbVie Nano-based Drug Delivery System Introduction
11.17.4 AbbVie Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.17.5 AbbVie Recent Development
11.18 Dr Reddy
11.18.1 Dr Reddy Company Detail
11.18.2 Dr Reddy Business Overview
11.18.3 Dr Reddy Nano-based Drug Delivery System Introduction
11.18.4 Dr Reddy Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.18.5 Dr Reddy Recent Development
11.19 AstraZeneca
11.19.1 AstraZeneca Company Detail
11.19.2 AstraZeneca Business Overview
11.19.3 AstraZeneca Nano-based Drug Delivery System Introduction
11.19.4 AstraZeneca Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.19.5 AstraZeneca Recent Development
11.20 Aspen
11.20.1 Aspen Company Detail
11.20.2 Aspen Business Overview
11.20.3 Aspen Nano-based Drug Delivery System Introduction
11.20.4 Aspen Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.20.5 Aspen Recent Development
11.21 Acrotech Biopharma
11.21.1 Acrotech Biopharma Company Detail
11.21.2 Acrotech Biopharma Business Overview
11.21.3 Acrotech Biopharma Nano-based Drug Delivery System Introduction
11.21.4 Acrotech Biopharma Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.21.5 Acrotech Biopharma Recent Development
11.22 TWi Pharmaceuticals
11.22.1 TWi Pharmaceuticals Company Detail
11.22.2 TWi Pharmaceuticals Business Overview
11.22.3 TWi Pharmaceuticals Nano-based Drug Delivery System Introduction
11.22.4 TWi Pharmaceuticals Revenue in Nano-based Drug Delivery System Business (2017-2022)
11.22.5 TWi Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Nano-based Drug Delivery System Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Less than 50nm
Table 3. Key Players of 50-150nm
Table 4. Key Players of 150-300nm
Table 5. Key Players of Others
Table 6. Global Nano-based Drug Delivery System Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Nano-based Drug Delivery System Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Nano-based Drug Delivery System Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Nano-based Drug Delivery System Market Share by Region (2017-2022)
Table 10. Global Nano-based Drug Delivery System Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Nano-based Drug Delivery System Market Share by Region (2023-2028)
Table 12. Nano-based Drug Delivery System Market Trends
Table 13. Nano-based Drug Delivery System Market Drivers
Table 14. Nano-based Drug Delivery System Market Challenges
Table 15. Nano-based Drug Delivery System Market Restraints
Table 16. Global Nano-based Drug Delivery System Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Nano-based Drug Delivery System Market Share by Players (2017-2022)
Table 18. Global Top Nano-based Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nano-based Drug Delivery System as of 2021)
Table 19. Ranking of Global Top Nano-based Drug Delivery System Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Nano-based Drug Delivery System Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Nano-based Drug Delivery System Product Solution and Service
Table 23. Date of Enter into Nano-based Drug Delivery System Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nano-based Drug Delivery System Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Nano-based Drug Delivery System Revenue Market Share by Type (2017-2022)
Table 27. Global Nano-based Drug Delivery System Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Nano-based Drug Delivery System Revenue Market Share by Type (2023-2028)
Table 29. Global Nano-based Drug Delivery System Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Nano-based Drug Delivery System Revenue Market Share by Application (2017-2022)
Table 31. Global Nano-based Drug Delivery System Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Nano-based Drug Delivery System Revenue Market Share by Application (2023-2028)
Table 33. North America Nano-based Drug Delivery System Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Nano-based Drug Delivery System Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Nano-based Drug Delivery System Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Nano-based Drug Delivery System Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Nano-based Drug Delivery System Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Nano-based Drug Delivery System Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Nano-based Drug Delivery System Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Nano-based Drug Delivery System Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Nano-based Drug Delivery System Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Nano-based Drug Delivery System Market Size by Country (2023-2028) & (US$ Million)
Table 43. Amgen Company Detail
Table 44. Amgen Business Overview
Table 45. Amgen Nano-based Drug Delivery System Product
Table 46. Amgen Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 47. Amgen Recent Development
Table 48. Teva Company Detail
Table 49. Teva Business Overview
Table 50. Teva Nano-based Drug Delivery System Product
Table 51. Teva Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 52. Teva Recent Development
Table 53. Roche Company Detail
Table 54. Roche Business Overview
Table 55. Roche Nano-based Drug Delivery System Product
Table 56. Roche Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 57. Roche Recent Development
Table 58. UCB (Union Chimique Belge) Company Detail
Table 59. UCB (Union Chimique Belge) Business Overview
Table 60. UCB (Union Chimique Belge) Nano-based Drug Delivery System Product
Table 61. UCB (Union Chimique Belge) Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 62. UCB (Union Chimique Belge) Recent Development
Table 63. Celgene Company Detail
Table 64. Celgene Business Overview
Table 65. Celgene Nano-based Drug Delivery System Product
Table 66. Celgene Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 67. Celgene Recent Development
Table 68. Merck Company Detail
Table 69. Merck Business Overview
Table 70. Merck Nano-based Drug Delivery System Product
Table 71. Merck Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 72. Merck Recent Development
Table 73. Gilead Sciences Company Detail
Table 74. Gilead Sciences Business Overview
Table 75. Gilead Sciences Nano-based Drug Delivery System Product
Table 76. Gilead Sciences Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 77. Gilead Sciences Recent Development
Table 78. Sanofi Company Detail
Table 79. Sanofi Business Overview
Table 80. Sanofi Nano-based Drug Delivery System Product
Table 81. Sanofi Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 82. Sanofi Recent Development
Table 83. Pfizer Company Detail
Table 84. Pfizer Business Overview
Table 85. Pfizer Nano-based Drug Delivery System Product
Table 86. Pfizer Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 87. Pfizer Recent Development
Table 88. Takeda Company Detail
Table 89. Takeda Business Overview
Table 90. Takeda Nano-based Drug Delivery System Product
Table 91. Takeda Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 92. Takeda Recent Development
Table 93. Bausch&Lomb Company Detail
Table 94. Bausch&Lomb Business Overview
Table 95. Bausch&Lomb Nano-based Drug Delivery SystemProduct
Table 96. Bausch&Lomb Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 97. Bausch&Lomb Recent Development
Table 98. Samyang Biopharmaceuticals Company Detail
Table 99. Samyang Biopharmaceuticals Business Overview
Table 100. Samyang Biopharmaceuticals Nano-based Drug Delivery SystemProduct
Table 101. Samyang Biopharmaceuticals Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 102. Samyang Biopharmaceuticals Recent Development
Table 103. Johnson & Johnson Company Detail
Table 104. Johnson & Johnson Business Overview
Table 105. Johnson & Johnson Nano-based Drug Delivery SystemProduct
Table 106. Johnson & Johnson Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 107. Johnson & Johnson Recent Development
Table 108. TOLMAR Company Detail
Table 109. TOLMAR Business Overview
Table 110. TOLMAR Nano-based Drug Delivery SystemProduct
Table 111. TOLMAR Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 112. TOLMAR Recent Development
Table 113. Astellas Company Detail
Table 114. Astellas Business Overview
Table 115. Astellas Nano-based Drug Delivery SystemProduct
Table 116. Astellas Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 117. Astellas Recent Development
Table 118. AMAG Pharmaceuticals Company Detail
Table 119. AMAG Pharmaceuticals Business Overview
Table 120. AMAG Pharmaceuticals Nano-based Drug Delivery SystemProduct
Table 121. AMAG Pharmaceuticals Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 122. AMAG Pharmaceuticals Recent Development
Table 123. AbbVie Company Detail
Table 124. AbbVie Business Overview
Table 125. AbbVie Nano-based Drug Delivery SystemProduct
Table 126. AbbVie Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 127. AbbVie Recent Development
Table 128. Dr Reddy Company Detail
Table 129. Dr Reddy Business Overview
Table 130. Dr Reddy Nano-based Drug Delivery SystemProduct
Table 131. Dr Reddy Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 132. Dr Reddy Recent Development
Table 133. AstraZeneca Company Detail
Table 134. AstraZeneca Business Overview
Table 135. AstraZeneca Nano-based Drug Delivery SystemProduct
Table 136. AstraZeneca Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 137. AstraZeneca Recent Development
Table 138. Aspen Company Detail
Table 139. Aspen Business Overview
Table 140. Aspen Nano-based Drug Delivery SystemProduct
Table 141. Aspen Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 142. Aspen Recent Development
Table 143. Acrotech Biopharma Company Detail
Table 144. Acrotech Biopharma Business Overview
Table 145. Acrotech Biopharma Nano-based Drug Delivery SystemProduct
Table 146. Acrotech Biopharma Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 147. Acrotech Biopharma Recent Development
Table 148. TWi Pharmaceuticals Company Detail
Table 149. TWi Pharmaceuticals Business Overview
Table 150. TWi Pharmaceuticals Nano-based Drug Delivery SystemProduct
Table 151. TWi Pharmaceuticals Revenue in Nano-based Drug Delivery System Business (2017-2022) & (US$ Million)
Table 152. TWi Pharmaceuticals Recent Development
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nano-based Drug Delivery System Market Share by Type: 2021 VS 2028
Figure 2. Less than 50nm Features
Figure 3. 50-150nm Features
Figure 4. 150-300nm Features
Figure 5. Others Features
Figure 6. Global Nano-based Drug Delivery System Market Share by Application in 2021 & 2028
Figure 7. Hydrophilic Drugs Case Studies
Figure 8. Hydrophobic Drugs Case Studies
Figure 9. Nano-based Drug Delivery System Report Years Considered
Figure 10. Global Nano-based Drug Delivery System Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Nano-based Drug Delivery System Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Nano-based Drug Delivery System Market Share by Region: 2021 VS 2028
Figure 13. Global Nano-based Drug Delivery System Market Share by Players in 2021
Figure 14. Global Top Nano-based Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nano-based Drug Delivery System as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Nano-based Drug Delivery System Revenue in 2021
Figure 16. North America Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Nano-based Drug Delivery System Market Share by Country (2017-2028)
Figure 18. United States Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Nano-based Drug Delivery System Market Share by Country (2017-2028)
Figure 22. Germany Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Nano-based Drug Delivery System Market Share by Region (2017-2028)
Figure 30. China Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Nano-based Drug Delivery System Market Share by Country (2017-2028)
Figure 38. Mexico Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Nano-based Drug Delivery System Market Share by Country (2017-2028)
Figure 42. Turkey Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Nano-based Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Amgen Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 45. Teva Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 46. Roche Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 47. UCB (Union Chimique Belge) Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 48. Celgene Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 49. Merck Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 50. Gilead Sciences Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 51. Sanofi Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 52. Pfizer Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 53. Takeda Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 54. Bausch&Lomb Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 55. Samyang Biopharmaceuticals Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 56. Johnson & Johnson Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 57. TOLMAR Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 58. Astellas Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 59. AMAG Pharmaceuticals Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 60. AbbVie Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 61. Dr Reddy Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 62. AstraZeneca Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 63. Aspen Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 64. Acrotech Biopharma Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 65. TWi Pharmaceuticals Revenue Growth Rate in Nano-based Drug Delivery System Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
